Plain-English translation of NCT04437329 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called works just as well as —the standard chemotherapy drug—for treating advanced nasopharyngeal cancer (a type of throat cancer). You would receive the medication in two phases: first as induction chemotherapy to shrink the tumor, and then alongside radiation therapy. The goal is to see if this newer medication is as effective while potentially causing fewer side effects.
has been the standard chemotherapy for this type of cancer for many years, but it can cause serious side effects, especially affecting the kidneys and hearing. This trial is exploring whether , a newer chemotherapy drug, can deliver the same cancer-fighting results with fewer or less severe side effects.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the new medication () or the standard medication (). Over about 9 weeks, you would receive three cycles of chemotherapy infusions given every 3 weeks, followed by radiation therapy that you would receive alongside additional chemotherapy cycles. Throughout treatment, you would have regular blood tests and scans to monitor how well the treatment is working and to check for side effects. The trial tracks your progress for several months to years to see how long you remain cancer-free.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China